Key result
Magnesium supplementation lowers systolic blood pressure by ~8 mm Hg.
RCT (n=17)
Double-blind
Cross-over
Answers are grounded in this paper and cite their sources.
Seventeen patients with a diastolic blood pressure over 90 mm Hg were recruited from a running health screening program to participate in a double blind cross-over study of magnesium supplementation (15 mmol Mg2+/day (Emgesan, Kabi Pharmacia) for 3 weeks, followed by 30 mmol Mg2+/day for another 3 weeks, finishing with 40 mmol Mg2+/day for a final 3 weeks). A significant decrease in the mean systolic blood pressure was recorded from 154.0 +/- 10.7 mm Hg to 146.1 +/- 16.9 mm Hg (P = .031) while the mean diastolic blood pressure decreased from 100.2 +/- 4.2 mm Hg to 92.0 +/- 6.6 mm Hg (P = .0001).
No takes yet. Share an insight, caveat, or question.
Widman et al. (1993) conducted an RCT in Hypertension (diastolic blood pressure > 90 mm Hg) (n=17). Magnesium supplementation (Emgesan) vs. Placebo was evaluated on Systolic and diastolic blood pressure (p=0.031). Magnesium supplementation decreased mean systolic BP from 154.0 to 146.1 mm Hg and diastolic BP from 100.2 to 92.0 mm Hg.
Synapse has enriched 10 related papers. Consider them for comparative context: